The API unit was established in 2008 with an oncology block which is currently under expansion and will reach a capacity of 24 million tone/year.
The R&D team was established in 2002 and covers all areas of product development from formulation sciences, analytical services, regulatory expertise and support services.
Founded in 1999 Accord's clinical research affiliate, is now one of the biggest CROs in India.
Accord's regulatory team is based in different parts of the globe with it's back office in India.
The Accord/ Intas groups total network operates 12 sites with supply to the EUMENA market from 6 significant EU cGMP and USFDA approved sites. This includes the Intas sites SEZ, Matoda, Moraiya and Dehradun.
Accord has a high degree of vertical integration with direct control over all steps of the development, registration, production, testing, quality control, supply chain and PV processes.
Accord has dedicated Quality Assurance resources based throughout the EU driven by the corporate office based in Harrow. In addition QA support is available at Intas plant & corporate levels.
Accord healthcare is young and dynamic, unencumbered by historical ways of operating and determined to make a big impact.
Our PV Services provide us with all pharmacovigilance requirements globally.